CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of $95.07 billion. The enterprise value is $97.53 billion.
| Market Cap | 95.07B |
| Enterprise Value | 97.53B |
Important Dates
The next confirmed earnings date is Wednesday, April 23, 2025, before market open.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | Mar 7, 2025 |
Share Statistics
CME Group has 360.38 million shares outstanding. The number of shares has increased by 0.12% in one year.
| Current Share Class | 360.38M |
| Shares Outstanding | 360.38M |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.31% |
| Owned by Institutions (%) | 90.19% |
| Float | 358.91M |
Valuation Ratios
The trailing PE ratio is 27.38 and the forward PE ratio is 24.52. CME Group's PEG ratio is 5.05.
| PE Ratio | 27.38 |
| Forward PE | 24.52 |
| PS Ratio | 15.76 |
| Forward PS | 15.13 |
| PB Ratio | 3.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 26.89 |
| P/OCF Ratio | 26.21 |
| PEG Ratio | 5.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.82, with an EV/FCF ratio of 27.12.
| EV / Earnings | 28.01 |
| EV / Sales | 15.94 |
| EV / EBITDA | 22.82 |
| EV / EBIT | 24.77 |
| EV / FCF | 27.12 |
Financial Position
The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.01 |
| Quick Ratio | 0.03 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.89 |
| Debt / FCF | 1.06 |
| Interest Coverage | 24.47 |
Financial Efficiency
Return on equity (ROE) is 13.25% and return on invested capital (ROIC) is 8.08%.
| Return on Equity (ROE) | 13.25% |
| Return on Assets (ROA) | 1.84% |
| Return on Invested Capital (ROIC) | 8.08% |
| Return on Capital Employed (ROCE) | 11.21% |
| Revenue Per Employee | $1.63M |
| Profits Per Employee | $925,931 |
| Employee Count | 3,760 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid $1.02 billion in taxes.
| Income Tax | 1.02B |
| Effective Tax Rate | 22.36% |
Stock Price Statistics
The stock price has increased by +26.61% in the last 52 weeks. The beta is 0.45, so CME Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +26.61% |
| 50-Day Moving Average | 252.66 |
| 200-Day Moving Average | 226.94 |
| Relative Strength Index (RSI) | 65.22 |
| Average Volume (20 Days) | 2,910,463 |
Short Selling Information
The latest short interest is 5.51 million, so 1.53% of the outstanding shares have been sold short.
| Short Interest | 5.51M |
| Short Previous Month | 5.01M |
| Short % of Shares Out | 1.53% |
| Short % of Float | 1.54% |
| Short Ratio (days to cover) | 2.39 |
Income Statement
In the last 12 months, CME Group had revenue of $6.12 billion and earned $3.48 billion in profits. Earnings per share was $9.67.
| Revenue | 6.12B |
| Gross Profit | 6.12B |
| Operating Income | 3.94B |
| Pretax Income | 4.25B |
| Net Income | 3.48B |
| EBITDA | 4.27B |
| EBIT | 3.94B |
| Earnings Per Share (EPS) | $9.67 |
Balance Sheet
The company has $3.01 billion in cash and $3.82 billion in debt, giving a net cash position of -$815.80 million or -$2.26 per share.
| Cash & Cash Equivalents | 3.01B |
| Total Debt | 3.82B |
| Net Cash | -815.80M |
| Net Cash Per Share | -$2.26 |
| Equity (Book Value) | 26.49B |
| Book Value Per Share | 73.66 |
| Working Capital | 719.60M |
Cash Flow
In the last 12 months, operating cash flow was $3.69 billion and capital expenditures -$94.00 million, giving a free cash flow of $3.60 billion.
| Operating Cash Flow | 3.69B |
| Capital Expenditures | -94.00M |
| Free Cash Flow | 3.60B |
| FCF Per Share | $9.98 |
Margins
Gross margin is 100.00%, with operating and profit margins of 64.32% and 57.61%.
| Gross Margin | 100.00% |
| Operating Margin | 64.32% |
| Pretax Margin | 74.20% |
| Profit Margin | 57.61% |
| EBITDA Margin | 69.83% |
| EBIT Margin | 64.32% |
| FCF Margin | 58.76% |
Dividends & Yields
This stock pays an annual dividend of $10.50, which amounts to a dividend yield of 3.97%.
| Dividend Per Share | $10.50 |
| Dividend Yield | 3.97% |
| Dividend Growth (YoY) | 8.25% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 108.58% |
| Buyback Yield | -0.12% |
| Shareholder Yield | 3.79% |
| Earnings Yield | 3.60% |
| FCF Yield | 3.72% |
Analyst Forecast
The average price target for CME Group is $241.13, which is -8.59% lower than the current price. The consensus rating is "Hold".
| Price Target | $241.13 |
| Price Target Difference | -8.59% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 4.64% |
| EPS Growth Forecast (5Y) | 8.35% |
Stock Splits
The last stock split was on July 23, 2012. It was a forward split with a ratio of 5:1.
| Last Split Date | Jul 23, 2012 |
| Split Type | Forward |
| Split Ratio | 5:1 |
Scores
CME Group has an Altman Z-Score of 0.6 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.6 |
| Piotroski F-Score | 6 |